|1.||Frangou, Sophia: 10 articles (06/2015 - 07/2003)|
|2.||Juuhl-Langseth, Monica: 9 articles (01/2015 - 07/2010)|
|3.||Thormodsen, Rune: 9 articles (01/2015 - 07/2010)|
|4.||Vitale, Michael G: 8 articles (12/2015 - 01/2010)|
|5.||Kumra, Sanjiv: 8 articles (03/2015 - 06/2004)|
|6.||Holmén, Aina: 7 articles (01/2015 - 07/2010)|
|7.||Rund, Bjørn Rishovd: 7 articles (07/2014 - 07/2010)|
|8.||Dellon, Evan S: 6 articles (03/2015 - 04/2010)|
|9.||Shaheen, Nicholas J: 6 articles (03/2015 - 04/2010)|
|10.||Tang, Jinsong: 6 articles (01/2015 - 01/2010)|
|1.||Asthma (Bronchial Asthma)
05/01/2008 - "This study was to investigate the effect of total flavonoid in leaves of Ginkgo biloba (total flavonoid in leaves of Ginkgo biloba, FG) on the apoptosis of eosinophils (EOS) in broncho alveloar lavage fluid (BALF) of asthma mice. "
03/01/2006 - "During the study period, the EOS strategy led to a significantly lower incidence of asthma exacerbations compared with the standard strategy group (0.22 and 0.78 exacerbations per year per patient, respectively). "
10/01/1991 - "This study suggests that mast cell and EOS degranulation is ongoing in the airway of patients with moderately symptomatic asthma."
04/01/2015 - "Measurement of FeNO is useful to evaluate the disease activity in children with asthma aged 1 to 3 years, but the FeNO values are not correlated with peripheral blood EOS count and lung function."
02/01/2015 - "Eosinophils (Eos) are potent inflammatory cells and abundantly present in the sputum and lung of patients with allergic asthma. "
10/01/2014 - "In EoE patients, initial PPI trial significantly decreased distal oesophageal eosinophilia (63.78 to 41.79 eos/HPF, P = 0.025) and led to symptom remission in 16%, but did not influence Th2 markers. "
02/01/2013 - "Two patients experienced initial resolution of symptoms and esophageal eosinophilia with PPI therapy; however, within 17-23 months they redeveloped symptoms and esophageal eosinophilia while receiving PPI therapy at the time of a third endoscopy (mean peak eosinophil count: 40 vs 11 vs 36 eos/HPF, and EPX index: 44 vs 21 vs 36.5, pre-, post- and posttreatment, respectively). "
10/01/2012 - "Both regimens significantly reduced Eos and CVAS throughout the treatment course, with abrogation of sputum eosinophilia at end of therapy. "
07/01/2011 - "Of the 14 patients with low grade esophageal eosinophilia who underwent repeat endoscopy a mean interval of 42 weeks (range 8-118 weeks) later, five (36%) met conventional diagnostic criteria for EoE of 15 or greater eos per HPF. "
07/01/2011 - "Fifty-nine adult patients without a previous diagnosis of EoE with esophageal biopsies containing 1-14 eos per HPF (low grade eosinophilia) and 418 adult patients with ≥15 eos per HPF were identified by retrospective review. "
07/01/2015 - "Distractible spinal growth rods are the gold standard when treating early-onset scoliosis (EOS). "
07/01/2014 - "To determine whether there is improvement in pulmonary function in children with early-onset scoliosis (EOS) using magnetic growth rods (MGRs). "
10/01/2012 - "Serial casting has demonstrated efficacy for idiopathic early-onset scoliosis (EOS). "
06/01/2015 - "The aim of this retrospective clinical study is to evaluate the effect of growing rod lengthening technique on sagittal balance in relationship with the spinopelvic parameters, in early onset scoliosis (EOS). "
12/01/2015 - "Early-onset scoliosis (EOS) can have negative effects on the developing thorax, lungs, and quality of life in general. "
10/01/2008 - "The multilevel probabilistic approach was more effective in assessing the diagnostic power of PCT in EOS, showing that a wide range of intermediate PCT values was not able to discriminate between presence and absence of infection."
04/01/2013 - "The aim of this study was to investigate whether determining PSP improves the diagnosis of EOS in comparison with other infection markers. "
06/01/2014 - "The CD64 index could be used as a reliable marker of EOS in VLBW neonates and it is an independent risk factor for late-onset infections."
01/01/2014 - "Reduction of diagnostic tests was associated with earlier antibiotic treatment in infants treated for suspected EOS (hazard ratio 1.58; 95% confidence interval [CI] 1.20-2.07; p <0.001), and in infants with neonatal infection (hazard ratio 2.20; 95% CI 1.19-4.06; p = 0.01). "
04/01/2013 - "However, traditional infection markers are poor diagnostic markers of EOS. "
|5.||Congenital Abnormalities (Deformity)
12/01/2010 - "Children with EOS present with a myriad of medical and orthopedic conditions associated with their specific diagnosis, and frequently require intensive preoperative evaluation and nutritional, pulmonary, and other support to prepare them for safe and effective treatment of the spinal/chest wall deformity. "
11/01/2015 - "In most patients with severe neuromuscular trunk deformities, the EOS system combined with our chair was useful for assessing preoperative trunk collapse, pelvic obliquity and postoperative corrections in all planes. "
07/01/2014 - "EOS deformities have large impacts on lung function and volumes. "
07/01/2014 - "EOS imaging device now reliably provides a global 3D quantitative analysis of scoliotic deformities in a context of routine clinical use. "
06/01/2013 - "This retrospective study was aimed at the evaluation of the spinal layout visualized by EOS 3D and vertebra vectors before and after surgical correction, the comparison of scoliotic spine measurement values based on 3D vertebra vectors with measurements using conventional two-dimensional (2D) methods, and an evaluation of horizontal plane vector parameters for their relationship with the magnitude of scoliotic deformity. "
|1.||Volatile Oils (Essential Oils)
|2.||Interleukin-5 (Interleukin 5)
|5.||Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
|7.||Proton Pumps (Proton Pump)
|9.||Adenosine Monophosphate (AMP)
|10.||Factor VIIa (Activated Factor VII)
|2.||Traditional Medicine (Folk Remedies)
|3.||Drug Therapy (Chemotherapy)
|4.||Neonatal Intensive Care
|5.||Combination Drug Therapy (Combination Chemotherapy)